TRAIL can specifically induce apoptosis by selectively binding to the TRAIL receptors on the surface of cancer cells, such as colon cancer cells, lung cancer cells, and glioma cells (Ion et al., 2019; Yoon et al., 2021). This evidence concerns the gene TNFSF10 and central nervous system cancer.